Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brinzolamide/Brimonidine FC for IOP prevention after Nd:YAG capsulotomy
NCT03192826Phase 4Completed
- Sponsor
- University General Hospital of Patras
- Start
- Jun 2016
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of brinzolamide in ocular hypertension (3 arms), sponsored by University General Hospital of Patras. Primary endpoints: Intraocular Pressure at 1 Hour, Intraocular Pressure at 3 Hours and 2 more. Started Jun 2016; status: completed.
02
Drugs
brinzolamide
03
Conditions
ocular hypertension
Beyond the preview
Go deeper on NCT03192826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03192826.